Effect of 25-OH-vitamin D3 on the Liver Transplant Recipients
The Clinical Effect of Preoperative Level of 25-OH-vitamin D3 on the Liver Transplant Recipients
1 other identifier
observational
219
1 country
1
Brief Summary
The low vitamin D3 levels and malnutrition before liver transplantation showed an increase in the length of stay in ICU and hospital. Although several factors may influence the clinical outcomes of patients with liver transplantation, low vitamin D3 levels showed an independent risk factor. It is necessary to prospectively analyze the effect of vitamin D supplements on clinical outcomes in liver transplant recipients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2017
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2019
CompletedFirst Submitted
Initial submission to the registry
September 29, 2019
CompletedFirst Posted
Study publicly available on registry
October 1, 2019
CompletedOctober 1, 2019
September 1, 2019
6 months
September 29, 2019
September 29, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Hospital stay after liver transplant
compared with each group
6 months
Secondary Outcomes (3)
duration of normalization of CRP, WBC
6 months
Length of ICU stay
6 months
New infection rate
6 months
Study Arms (3)
1
Liver transplant patients with severe vitamin D deficiency (\<10ng/ml)
2
Liver transplant patients with vitamin D insufficiency (10-20ng/ml)
3
Liver transplant patients with normal vitamin D status (\>20ng/ml)
Eligibility Criteria
Patients received liver transplantation from June 2017 to November 2017
You may qualify if:
- The patients who admitted to intensive care unit (ICU) after liver transplantation were studied
You may not qualify if:
- Patients who didn't have preoperative vitamin D level
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hakjae Lee
Seoul, South Korea
Related Publications (4)
Finkelmeier F, Kronenberger B, Koberle V, Bojunga J, Zeuzem S, Trojan J, Piiper A, Waidmann O. Severe 25-hydroxyvitamin D deficiency identifies a poor prognosis in patients with hepatocellular carcinoma - a prospective cohort study. Aliment Pharmacol Ther. 2014 May;39(10):1204-12. doi: 10.1111/apt.12731. Epub 2014 Mar 29.
PMID: 24684435RESULTFinkelmeier F, Kronenberger B, Zeuzem S, Piiper A, Waidmann O. Low 25-Hydroxyvitamin D Levels Are Associated with Infections and Mortality in Patients with Cirrhosis. PLoS One. 2015 Jun 29;10(6):e0132119. doi: 10.1371/journal.pone.0132119. eCollection 2015.
PMID: 26121590RESULTGrant C. A vitamin D protocol post-liver transplantation. J Am Assoc Nurse Pract. 2017 Nov;29(11):658-666. doi: 10.1002/2327-6924.12503. Epub 2017 Aug 25.
PMID: 28840965RESULTZhou Q, Li L, Chen Y, Zhang J, Zhong L, Peng Z, Xing T. Vitamin D supplementation could reduce the risk of acute cellular rejection and infection in vitamin D deficient liver allograft recipients. Int Immunopharmacol. 2019 Oct;75:105811. doi: 10.1016/j.intimp.2019.105811. Epub 2019 Aug 15.
PMID: 31422183RESULT
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 29, 2019
First Posted
October 1, 2019
Study Start
June 1, 2017
Primary Completion
November 30, 2017
Study Completion
June 30, 2019
Last Updated
October 1, 2019
Record last verified: 2019-09
Data Sharing
- IPD Sharing
- Will not share